Paul Choi
Stock Analyst at Goldman Sachs
(0)
# 4649
Out of 5,345 analysts
142
Total ratings
44.44%
Success rate
-17.45%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
URGN UroGen Pharma | Maintains: Neutral | 16 3 | 4.04 | -25.74% | 4 | May 22, 2025 | |
GOSS Gossamer Bio | Maintains: Strong Buy | 7 8 | 1.17 | 583.76% | 6 | May 16, 2025 | |
PHAT Phathom Pharmaceutic... | Maintains: Neutral | 10 5 | 4.07 | 22.85% | 10 | May 2, 2025 | |
ARVN Arvinas | Maintains: Neutral | 12 8 | 7.25 | 10.34% | 3 | May 2, 2025 | |
XENE Xenon Pharmaceutical... | Maintains: Buy | 60 52 | 28.94 | 79.68% | 2 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 28 21 | 4.73 | 343.97% | 8 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 14 12 | 8.51 | 41.01% | 3 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 4 3 | 0.84 | 257.14% | 9 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 12 10 | 9.59 | 4.28% | 4 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 20 7 | 11.6 | -39.66% | 7 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 200 225 | 159.1 | 41.42% | 4 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 143 | 74.33 | 92.39% | 1 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 32 42 | 47.59 | -11.75% | 7 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 85 60 | 30.59 | 96.14% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 17 19 | 13.16 | 44.38% | 6 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 22 32 | 27.46 | 16.53% | 1 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 29 50 | 32.58 | 53.47% | 6 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 21 19 | 4.04 | 370.3% | 3 | Jun 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 16 2 | 0.32 | 525% | 7 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 29 26 | n/a | n/a | 2 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 29 4 | n/a | n/a | 1 | Oct 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 43 25 | 0.9 | 2677.78% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 450 100 | n/a | n/a | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 10 4 | n/a | n/a | 4 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 25 4 | n/a | n/a | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 151 170 | 15.46 | 999.61% | 2 | Oct 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 225 125 | n/a | n/a | 2 | Sep 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 9 8 | 3.39 | 135.99% | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | 132 | n/a | n/a | 3 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 33 | 29.57 | 11.6% | 1 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 112 | 46.7 | 139.83% | 1 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 30 | n/a | n/a | 1 | Jan 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 28 | n/a | n/a | 1 | Aug 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 48 49 | n/a | n/a | 4 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 91 103 | n/a | n/a | 2 | Jul 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 135 | 123.43 | 9.37% | 1 | Jun 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 240 | n/a | n/a | 2 | Jun 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 5 22 | n/a | n/a | 3 | Apr 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 18 20 | 0.7 | 2757.14% | 2 | Mar 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 58 40 | n/a | n/a | 3 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 60 56 | n/a | n/a | 3 | Aug 6, 2018 |